Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Breast Cancer Vaccines
Research add new data to breast cancer vaccines body of knowledge
April 28th, 2005
New findings from the United States and Italy describe advances in breast cancer vaccines. Study 1: Killed Mycobacterium vaccae may augment the efficacy of trastuzumab in metastatic breast cancer patients. "SRL172, non-specific immunological adjuvant downregulates interleukin (IL)-4, upregulates IL-2 production, switching towards a T-helper-1 response, induces an increase in natural killer cells and activates antigen presenting cells. The human epidermal growth factor receptor 2 gene amplification is frequently observed in a number of primary tumors, suggesting that the overexpression of this growth factor receptor may contribute to...
Source: Women's Health Weekly (2005-04-28)
|
